Taiwan Clears First Trial Of Stem Cell Technology
This article was originally published in PharmAsia News
Executive Summary
Taiwan's government has given its approval for local biotech Bionet to conduct the first clinical test of mesenchymal stem cell transplants in the country. That trial is the first of six trials Bionet plans, all under the sponsorship of the government. The first trial is to see if mesenchymal cells assist transplanted umbilical blood stem cells in treating leukemia and other diseases caused by hematopoietic stem cells that do not work correctly. (Click here for more